(Press-News.org) A new guideline on consent for clinical research that puts participant needs first and will help streamline approvals is published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250500.
“The purpose of this guidance for policy is to present a core set of elements for participant consent documents to be used in clinical research across Canada and to facilitate harmonization of multi-site projects by simplifying the approval process for all those involved,” writes Dr. Holly Longstaff, British Columbia’s Provincial Health Services Authority and the Children’s and Women’s Health Centre of British Columbia Research Ethics Board, University of British Columbia, Vancouver, BC, with coauthors. “These core elements can be also used as a research ethics tool when evaluating research projects with human participants.”
Developed by the Canadian Critical Care Trials Group in partnership with the Canadian Institutes of Health Research, the objective is that all researchers who apply to a Canadian research ethics board for approval will use the consent guidance, which is summarized in a downloadable template, to document informed consent.
“Regulatory elements have become mandatory for all study types, and the inclusion of institutional risk-management elements is common practice,” write the authors. “This has resulted in bloated consent forms that, in many cases, do little to help the participant understand the risk elements and, in some cases, have even been shown to detract from a person’s ability to make an informed decision.”
The guideline sets out 75 core elements for participant consent forms to ensure transparency and participant understanding of their involvement in research studies, including sections such as “What do you need to know about taking part in research?”, “What does taking part in this study involve?”, “What are the possible harms and benefits of taking part in this study?”, and more.
If used, this core set of elements, which has been organized into a fillable template for ease of use, is sufficient to meet regulatory requirements for research in Canada.
The guideline, template, and guidance elements are available in a range of formats at https://www.ccctg.ca/core-consent for immediate use.
END
New guideline standardizes consent for research participants in Canada
2025-09-15
ELSE PRESS RELEASES FROM THIS DATE:
Research as reconciliation: Oil sands and health
2025-09-15
Canada’s government and health science sectors should commit to researching the health effects of oil sands tailings, as previous research suggests that air, water, and land contaminations negatively affect local people’s health, authors urge in a CMAJ (Canadian Medical Association Journal) commentaryhttps://www.cmaj.ca/lookup/doi/10.1503/cmaj.240643.
The Alberta oil sands occupy a large area of land, and Indigenous Peoples as well as others have expressed concern about the health impacts of oil sands and tailings ponds. A community-led study showed elevated levels of contaminants in some animal food sources, such as duck and moose, as well as a higher rate of rare cancers in ...
AI risks overwriting history and the skills of historians have never been more important, leading academic outlines in new paper
2025-09-15
Human historians are ever more vital in the age of AI – especially with the crucial need to capture the emotional and moral complexity behind world events.
That’s according to a leading academic Dr Jan Burzlaff, an expert on Nazi Germany from Cornell University, who when tasking ChatGPT to summarize the experiences of Holocaust survivors found the AI tool failed to capture intimate, vital details.
“With the testimony of Luisa D., a seven-year-old Holocaust survivor, AI overlooked heartbreaking details about her mother cutting her own finger to give her dying child drops of blood – ‘the faintest trace of moisture’ – to stay ...
The Lancet Diabetes & Endocrinology: Higher doses of semaglutide can safely enhance weight loss and improve health for adults living with obesity, two new clinical trials confirm
2025-09-14
A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to the results of two large-scale, international phase 3 clinical trials. The findings, published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people with obesity, including those with T2D, who have not achieved sufficient weight loss with existing treatments.
The STEP UP and STEP UP T2D clinical trials are the first to investigate whether increasing ...
Trauma focused therapy shows promise for children struggling with PTSD
2025-09-14
A specialist form of therapy could offer hope for some of the most vulnerable young PTSD sufferers – according to a University of East Anglia study.
Researchers investigated the effectiveness of trauma-focused cognitive-behavioural therapy (CBT) for treating children who had been through multiple traumas such as abuse, violence or serious accidents.
While this type of therapy is already known to help with PTSD, the new study focused on children who had experienced multiple traumas - a group often considered harder ...
School meals could drive economic growth and food system transformation
2025-09-14
School meals, provided for free by governments around the world, could be used to curb global hunger and promote a sustainable global food system, finds a new study by UCL (University College London) researchers.
In a new report, “A Mission-Oriented Approach to School Meals: An opportunity for cross-departmental and multi-sector industrial strategy”, published by UCL Institute of Innovation and Public Purpose in collaboration with the UN World Food Programme, researchers looked at ways governments can use school meals procurement to encourage ...
Home training for cerebellar ataxias
2025-09-14
About The Study: In this randomized clinical trial, home high-intensity aerobic training improved ataxia symptoms, fatigue, and aerobic fitness more than dose-matched home balance training among individuals with cerebellar ataxias, a heterogenous group of disorders characterized by progressive disability due to loss of coordination. Individuals in the aerobic group who continued to train regularly maintained benefits at 1 year.
Corresponding Author: To contact the corresponding author, Scott Barbuto, MD, PhD, email sb3779@cumc.columbia.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2025.3421)
Editor’s ...
Dry eyes affect over half the general population, yet only a fifth receive diagnosis and treatment
2025-09-14
Copenhagen, Denmark: Dry eyes can cause significant discomfort, and the symptoms become more common as we age. However, until now, it was unclear what proportion of the population suffered from the condition, with estimates ranging from 5-50%.
In fact, research presented today (Monday) at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) [1], found that more than half of the general population in the USA and Europe experience dry eyes, yet only 20% of European patients and 17% of US patients were diagnosed, and they can wait years for professional help.
Dr Piotr ...
Researchers sound warning about women with type 2 diabetes taking oral HRT
2025-09-14
In women with type 2 diabetes (T2D), use of hormone replacement therapy (HRT) skin patches is not associated with a higher risk of blood clots or stroke. However, an increased cardiovascular risk was found for oral HRT, according to a large real-world study being presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept).
Among the findings are an analysis revealing women with T2D who took the oral form of HRT doubled their risk of developing a pulmonary embolism (PE - when a blood clot blocks an artery in the lung) and faced a 21% increased risk of heart disease compared with ...
Overweight and obesity don’t always increase the risk of an early death, Danish study finds
2025-09-14
It is possible to be “fat but fit”, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) suggests.
The study of tens of thousands of people in Denmark found that those with a BMI in the overweight category – and even some of those living with obesity – were no more likely to die during the five years of follow-up than those with a BMI of 22.5-<25.0 kg/m2, which is at the top end of the normal weight range.
Individuals with a BMI in the middle and lower parts of the normal ...
Cannabis use associated with a quadrupling of risk of developing type 2 diabetes, finds study of over 4 million adults
2025-09-14
Cannabis use is linked to an almost quadrupling in the risk of developing diabetes, according to an analysis of real-world data from over 4 million adults, being presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 Sept).
Cannabis use is increasing globally with an estimated 219 million users (4.3% of the global adult population) in 2021, but its long-term metabolic effects remain unknown [1]. While some studies have suggested potential anti-inflammatory or weight management properties, others have raised concerns regarding ...